ARPA-H describes ADVOCATE as intended to develop clinical AI agents for cardiovascular-care tasks plus supervisory post-deployment monitoring.

Provenance

First verified

2026-01-13

Source date (official launch release)

2026-01-13

Revision state

Version 1.1 recasts ADVOCATE as a prospective program objective, records the closed solicitation and no-results boundary, and records the September 3, 2026 re-verification.

Last verified

2026-09-03

Status

Prospective program objective · solicitation closed 2026-04-01 · no results reported

Freshness

Changed

Version

1.1

Fingerprint

ac35fd916b6570d4

Change sensitivity

High

Evidence limits

The source reports no selected performer, deployed system, validation, FDA authorization, clinical effect, or result.

Primary source

https://arpa-h.gov/explore-funding/programs/advocate

Related signals

• SIG-2026-017 — ARPA-H ADVOCATE describes a prospective clinical-agentic-AI objective